Intervention Protocol

You have free access to this content

Naloxone for reducing mortality and adverse neurological outcomes following acute traumatic brain injury

  1. Jin Lei,
  2. Guoyi Gao*,
  3. Jiyao Jiang

Editorial Group: Cochrane Injuries Group

Published Online: 22 AUG 2013

DOI: 10.1002/14651858.CD010679.pub2


How to Cite

Lei J, Gao G, Jiang J. Naloxone for reducing mortality and adverse neurological outcomes following acute traumatic brain injury (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD010679. DOI: 10.1002/14651858.CD010679.pub2.

Author Information

  1. Renji Hospital, Shanghai Jiaotong University School of Medicine, Department of Neurosurgery, Shanghai, China

*Guoyi Gao, Department of Neurosurgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, 1630 Dongfang Road, Shanghai, 200127, China. guoyigao@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 22 AUG 2013

SEARCH

References

Additional references

Baskin 1981
Calvanio 2000
  • Calvanio R, Burke DT, Kim HJ, Cheng J, Lepak P, Leonard J, et al. Naltrexone: effects on motor function, speech, and activities of daily living in a patient with traumatic brain injury. Brain Injury 2000;14(10):933-42.
Chang 2000
  • Chang RC, Rota C, Glover RE, Mason RP, Hong JS. A novel effect of an opioid receptor antagonist, naloxone, on the production of reactive oxygen species by microglia: a study by electron paramagnetic resonance spectroscopy. Brain Research 2000;854(2000):224-9.
Chatterjie 1996
  • Chatterjie N, Alexander GJ, Sechzer JA, Lieberman KW. Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity. Neurochemical Research 1996;21(6):691-3.
Chen 2000
  • Chen CJ, Cheng FC, Liao SL, Chen WY, Lin NN, Kuo JS. Effects of naloxone on lactate, pyruvate metabolism and antioxidant enzyme activity in rat cerebral ischemia/reperfusion. Neuroscience Letters 2000;287(2):113-6.
Chen 2002
  • Chen B, Liu YS. Randomized double-blind clinical trial of moderate dosage naloxone in acute moderate and severe traumatic brain injury. Hunan Yi Ke Da Xue Xue Bao 2002;27(1):58-60.
Faden 1983
  • Faden AI. Opiate antagonists in the treatment of stroke. Current Concepts of Cerebrovascular Disease: Stroke 1983;18:27-3t.
Faden 1986
Faden 1996
Fallis 1984
Gentile 1993
  • Gentile NT, McIntosh TK. Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury. Annals of Emergency Medicine 1993;22(6):1028-34.
Ghajar 2000
Hayes 1983
  • Hayes RL, Galinat BJ, Kulkarne P, Becker DP. Effects of naloxone on systemic and cerebral responses to experimental concussive brain injury in cats. Journal of Neurosurgery 1983;58(5):720-8.
Hayes 1990
  • Hayes RL, Lyeth BG, Jenkins LW, Zimmerman R, McIntosh TK, Clifton GL, et al. Possible protective effect of endogenous opioids in traumatic brain injury. Journal of Neurosurgery 1990;72(2):252-61.
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. The Cochrane Collaboration.
Hoffman 1995
Hosobuchi 1982
Jabaily 1984
JinErLun Study Group 2001
  • JinErLun Study Group 2001. A parallel randomised double-blind multi-centre clinical trial of the efficacy and safety of JinErLun (hydrochloride naloxone) in acute traumatic brain injury. Chinese Journal of Neurosurgery 2001;17(3):135-9.
Knapp 1998
Liao 2003
Liu 2000
  • Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. The Journal of Pharmacology and Experimental Therapeutics 2000;293(2):607-17.
Liu 2002
  • Liu Y, Qin L, Wilson BC, An L, Hong JS, Liu B. Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. The Journal of Pharmacology and Experimental Therapeutics 2002;302(3):1212-9.
Maas 2010
McGarry 2002
  • McGarry LJ, Thompson D, Millham FH, Cowell L, Snyder PJ, Lenderking WR, et al. Outcomes and costs of acute treatment of traumatic brain injury. Journal of Trauma 2002;53(6):1152-9.
McIntosh 1993
  • McIntosh TK, Fernyak S, Hayes RL, Faden AI. Beneficial effect of the nonselective opiate antagonist naloxone hydrochloride and the thyrotropin-releasing hormone (TRH) analog YM-14673 on long-term neurobehavioral outcome following experimental brain injury in the rat. Journal of Neurotrauma 1993;10(4):373-84.
McIntosh 1994
  • McIntosh TK, Faden AI. Endogenous opioid peptides and traumatic central nervous system injury. In: Salzman SK, Faden AI editor(s). Neurobiology of Central Nervous System Trauma. New York: Oxford University Press, 1994:165-72.
Parikh 2007
  • Parikh S, Koch M, Narayan RK. Traumatic brain injury. International Anesthesiology Clinics 2007;45(3):119-35.
Review Manager 5
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Ware 1992